2018抗體藥物研討會 Antibody Therapeutics Conference Immuno-Oncology, and Beyond 

2018抗體藥物研討會宣傳海報 2018年12月4日(星期二) 國家生技研究園區 (C棟)國際會議廳

台灣抗體協會與生物技術開發中心將於2018年12月4日(星期二)於國家生技研究園區 (C棟)國際會議廳共同舉辦「2018 Antibody Therapeutics Conference Immuno-Oncology, and Beyond」。抗體協會自2013年舉辦第一屆ATC論壇，自今已第五個年頭，這幾年各國皆如火如荼地投入抗體治療的應用與開發，也有不少成功的進程，台灣當然也不例外，可以感受到產、官、學、研積極投入。除了新標的抗體的開發，如何有效連結產業鏈，成為台灣學研機構共同面臨的課題。

今年的論壇探討關於當前趨勢和未來機會，期待透過您的參與討論，能夠讓論壇更加精采可期。活動詳情請洽下方EDM或活動網站活動網站連結

期待您的蒞臨！

The Antibody Therapeutics Conference (ATC) is a one-day event which will be held at the National Biotechnology Research Park in Taipei on 4th December, 2018. The theme of the event is "Immuno-Oncology and Beyond”, focusing on immunotherapy to uncover the future of cancer therapy

Online registration for ATC 2018 is open! We are pleased to offer reduced conference registration rates to Taiwan Antibody Association members and discount for early registration. To register for ATC conference, click>>> Accupass.

 

2018抗體藥物研討會講者照片

>>>Antibody Therapeutics Conference (ATC) website: Antibody Therapeutics Conference (ATC) website

 

Scientific Program

Time

Topic and Speaker

08:30 - 09:00

Registration

09:00 - 09:05

Opening Remarks
Lawrence Gan, Ph.D
Director of Taiwan Antibody Association; President/CEO, Foresee Pharmaceuticals

09:05 - 09:10

Herbert Wu, Ph.D.
President, Development Center for Biotechnology

Opening Keynote

Moderator
09:10 - 09:15

Yun Yen, M.D., Ph.D.
President Emeritus of Taipei Medical University, Chair Professor of the Ph.D. Program for Cancer Biology and Drug Discovery

09:15 - 10:00

Cancer Cell Cast a Sweet Spell on Tumor Microenvironment: Opportunities and Challenges 
Alice Yu, M.D., Ph.D.
Distinguished Professor & Co-Director of the Institute of Stem Cell & Cancer Translational Research in Chang Gung Memorial Hospital

10:00 - 10:30

Break

Moderator
10:30 - 10:35

Shie-Liang Edmond Hsieh, M.D., D.Phil.
Distinguished Research Fellow, Genomics Research Center, Academia Sinica

10:35 - 11:05

Defining the Difference: Developing Translational Screening Models to Mimic Tumor Microenvironment
Litao Zhang, Ph.D.
VP, Leads Discovery & Optimization R&D, Bristol-Myers Squibb

11:05 - 11:35

What You Eat Makes You Strong but Vulnerable : Metabolic Targeting of Intramural Tregs in Cancer Immunotherapy 
Ping-Chih Ho, Ph.D.
Assistant Professor/Ludwig adjunct scientist 
Department of oncology UNIL CHUV/Ludwig Institute for Cancer Research Lausanne

11:35 - 12:05

Finding Better Combinations of Immunotherapy 
Keng-Li Lan, M.D., Ph.D.
Associate Professor, Institute of Traditional Medicine, School of Medicine, National Yang-Ming University;Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital

12:05 - 13:40

Lunch (Taiwan Antibody Association Members Meeting and Poster Viewing)

12:15 - 12:45

Lunch Panel / Industry satellite symposium

Moderator
13:40 - 13:45

Ping-Ning Hsu, M.D., Ph.D.
Professor, Graduate Institute of Immunology, College of Medicine, National Taiwan University

13:45 - 14:15

Understanding Immune Checkpoint TIM-3 Biology and TIM-3 Antibody for Cancer Immunotherapy 
Xiaomo Jiang , Ph.D.
Investigator II, Exploratory Immuno-Oncology, Novartis Institutes for Biomedical Research

14:15 - 14:45

Clinical Experience and Safety Management of Immunotherapy 
John Wen-Cheng Chang, M.D.
Chief, Division of Medical Oncology, Chang Gung Memorial Hospital; Director, Immune-Oncology Center of Excellence, Chang Gung Memorial Hospital; Chairman, Taiwan Society for Immunotherapy of Cancer

14:45 - 15:15

Current Progress of Immunotherapy for Non-small Cell Lung Cancer
Chih-Hsin Yang, M.D., Ph.D.
Professor & Director, Graduate Institute of Oncology, College of Medicine, National Taiwan University

15:15 - 15:45

Break

15:45 - 16:00

Poster Award

Closing Keynote

Moderator
16:00 - 16:05

Herbert Wu, Ph.D.
President, Development Center for Biotechnology

16:05 - 16:50

Engineering Adaptive Cell and Gene Therapies 
Timothy K. Lu, Ph.D.
Associate Professor Synthetic Biology Group, Research Laboratory of Electronics, Electrical Engineering and Computer Science, Biological Engineering, Massachusetts Institute of Technology

16:50 - 17:00

Closing Remarks 
Herbert Wu, Ph.D.
President, Development Center for Biotechnology